Ma. Borg et al., Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats, DIABETES, 48(3), 1999, pp. 584-587
Previous studies have demonstrated that the ventromedial hypothalamus (VMH)
plays a critical role in sensing and responding to systemic hypoglycemia.
To evaluate the mechanisms of defective counterregulation caused by iatroge
nic hypoglycemia and diabetes per se, we delivered 2-deoxy-glucose (2-DG) v
ia microdialysis into the VMH to produce localized cellular glucopenia in t
he absence of systemic hypoglycemia. Three groups of awake chronically cath
eterized rats were studied: 2) nondiabetic (with a mean daily glucose [MDG]
of 6.9 mmol/l) BE control rats (n = 5); 2) chronically hypoglycemic nondia
betic (3-4, weeks, with an MDG of 2.7 mmol/l) BE rats (n = 5); and 5) moder
ately hyperglycemic insulin-treated diabetic (with an MDG of 12.4 mmol/l) B
E rats (n = 8). In hypoglycemic rats, both glucagon and catecholamine respo
nses to VMH glucopenia were markedly (77-93%) suppressed. In diabetic rats,
VMH 2-DG perfusion was totally ineffective in stimulating glucagon release
. The epinephrine response, but not the norepinephrine response, was also d
iminished by 38%, in the diabetic group. We conclude that impaired counterr
egulation after chronic hypoglycemia may result from alterations of the VMH
or its efferent pathways. In diabetes, the capacity of VMH glucopenia to a
ctivate the sympathoadrenal system is only modestly diminished; however the
communication between the VMH and the alpha-cell is totally interrupted.